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Prostate specific antigen 
Dear Editor
I would like to commend the article ‘Prostate 
specific antigen’1 by Professor Tom Brett (AFP July 
2011). I am a medical student in my second last 
year of medical school and breathed a sigh of relief 
after reading this article, which succinctly explained 
the facts behind the controversial topic of PSA as a 
screening test and emphasised its importance for 
the surveillance of various prostate pathologies. 
The article provided the fundamental 
information requiring consideration prior 
to PSA testing such as timing, indications, 
contraindications and significance of patient 
counselling and management post-results. It 
also highlighted the significance of applying 
methods to improve the predictive value of the 
test results by combining PSA testing with digital 
rectal examination and considering age specific 
ranges, free-to-total PSA ratios and prostate 
specific antigen velocity. I especially enjoyed the 
case studies which reiterate the importance of 
considering the clinical context in the interpretation 
of a raised PSA and its usefulness across various 
clinical scenarios. 
My only disappointment is that the article didn’t 
come along sooner, as I have found it extremely 
beneficial for my understanding of the PSA test. 
I recommend it as a useful learning resource for 
medical students and medical professionals. 
Maeve Kiely 
Perth, WA 
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Prostate cancer testing
Dear Editor
The Royal Australian College of General 
Practitioners (RACGP), the Royal College of 
Pathologists Australasia and the Urological 
Society Australia and New Zealand currently have 
conflicting guidelines on prostate cancer testing. It 
is therefore, I believe, important that the RACGP and 
its peer review journal, Australian Family Physician 
(AFP), provide consistent, evidence based and up-to-
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Anxiety disorders
Dear Editor
Regarding the article, ‘Anxiety disorders – 
assessment and management in general practice’1 
(AFP June 2011), I am concerned at the amount 
of time it took for the two ‘case study patients’ to 
get better with psychological help in the absence 
of medication; several months for a significant 
response, and up to 6 or more months in case 1. 
The patients described in both cases had significant 
and distressing symptoms; both patients describe 
being unable to leave the house, even for work, and 
the second patient had symptoms of depression; 
severe enough for a diagnosis of a major depressive 
episode. In both cases, medication should have 
been prescribed early. 
 In my experience as a GP, medication plus 
behavioural therapy could have reduced the time 
taken to achieve a significant response to 4–6 
weeks. Unfortunately, both cases waited far too 
long to see a result through behavioural therapy 
alone. As GPs we should not be encouraging the 
early referral of such patients to psychologists 
without the prescription of an appropriate 
medication and close medical follow up. 
Dr Vivienne Miller
Sydney, NSW
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date information about prostate cancer testing. 
The medicolegal consequences of differing 
opinions were summed up by Mahar,1 who 
concluded: ‘The decision by a GP to order a PSA test, 
whether opportunistically or at the patient’s request, 
has not been made easier following the inconclusive 
and conflicting results of recent randomised 
controlled trials. Authoritative medical opinions in 
Australia differ in their approach to PSA testing, and 
GPs have an ongoing duty to determine their own 
position in this regard. Nonetheless, whether a GP 
orders a PSA test or not, such an act or omission is 
unlikely to be considered negligent so long as it is 
supported by a responsible body of medical opinion’.
Unfortunately the responsible body of opinion 
within general practice is currently providing 
inconsistent information about prostate cancer 
testing, which may be placing GPs at medicolegal 
risk. For example, a PSA test patient information 
sheet2 recently published in AFP (July 2011) stated, 
‘The use of PSA as a screening test for prostate 
cancer remains controversial because trials have not 
shown PSA testing for early detection of prostate 
cancer leads to a reduction in deaths’. While I agree 
that prostate cancer testing is controversial, this 
statement is at odds with an earlier AFP article3 
which quoted the European Randomised study for 
Screening in Prostate Cancer (ERSPC) showing an 
advantage in survival to men who were screened, 
with a relative reduction in death from prostate 
cancer by 20%. 
In addition, the AFP patient fact sheet failed 
to outline many of the risks and uncertainties of 
prostate testing as documented in the fact sheets 
attached to the current RACGP guideline.4 
At present, it is very difficult for GPs to give 
their patients a fully informed choice about prostate 
cancer testing and treatment, within the time 
limitations of consultations without evidence based 
resources. In order to allow authors to fully present 
the controversies surrounding the detection and 
treatment of prostate cancer in a balanced way, 
I would respectfully suggest that AFP allocates 
a future edition to the topic of prostate cancer, a 
common cancer diagnosed in 1 in 5 Australian men.  
Adjunct Associate Professor Leanne Rowe AM
Southbank, Vic
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